The Journal of Thoracic and Cardiovascular Surgery
Volume 137, Issue 1 , Pages 20-22 , January 2009

COUNTERPOINT: Despite staging inaccuracies, patients with non–small cell lung cancer are best served by having integrated positron emission tomography/computed tomography before therapy

  • Robert J. Cerfolio, MD, FACS, FCCP

      Affiliations

    • Corresponding Author InformationAddress for reprints: Robert J. Cerfolio, MD, FACS, FCCP, Professor, Department of Surgery, Chief of Thoracic Surgery, Division of Cardiothoracic Surgery, University of Alabama at Birmingham (UAB), 703 19th St S, ZRB 739, Birmingham, AL 35294.

Received 21 June 2008 ,Accepted 29 August 2008.

References 

  1. Stiles BM, Lee PC, Servais EC, Port JL, Paul S, Meherally D, et al. Clinical stage IA lung cancer by CT and PET scan: the persistent problem of understaging. J Thorac Cardiovasc Surg. 2009;137:13–19
  2. Cerfolio RJ, Ojha B, Bryant AS, Raghuveer V, Mountz JM, Bartolucci AA. The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer. Ann Thorac Surg. 2004;78:1017–1023
  3. Shim SS, Lee KS, Kim BT, Chung MJ, Lee EJ, Han J, et al. Non–small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. Radiology. 2005;236:1011–1019
  4. Lardinois D, Weder W, Hany TF, Kamel EM, Korom S, Seifert B, et al. Staging of non–small cell lung cancer with integrated positron emission tomography and computed tomography. N Engl J Med. 2003;348:2500–2507
  5. Cerfolio RJ, Bryant AS, Ojha B, Eloubeidi M. Improving the inaccuracies of clinical staging of patients with NSCLC: a prospective trial. Ann Thorac Surg. 2005;80:1207–1213
  6. Cerfolio RJ, Bryant AS, Ojha B. Restaging patients with N2 (stage IIIa) non–small cell lung cancer after neoadjuvant chemoradiotherapy: a prospective study. J Thorac Cardiovasc Surg. 2006;131:1229–1235Erratum in: J Thorac Cardiovasc Surg. 2006;132:565-7
  7. Cerfolio RJ, Bryant AS. Is palpation of the nonresected pulmonary lobe(s) required for patients with non–small cell lung cancer? A prospective study. J Thorac Cardiovasc Surg. 2008;135:261–268
  8. Erasmus JJ, Macaplinac HA, Swisher SG. Positron emission tomography imaging in non small–cell lung cancer. Cancer. 2007;110:2155–2168
  9. Craanen ME, Comens EF, Paul MA, Smit EF. Endoscopic ultrasound guided fine-needle aspiration and 18FDG-positron emission tomography in the evaluation of patients with non–small cell lung cancer. Interact Cardiovasc Thorac Surg. 2007;6:433–436
  10. Yasufuku K, Nakajima T, Motoori K, Sekine Y, Shibuya K, Hiroshima K, et al. Comparison of endobronchial ultrasound, positron emission tomography, and CT for lymph node staging of lung cancer. Chest. 2006;130:710–718
  11. Bryant AS, Cerfolio RJ, Klemm KM, Ojha B. Maximum standard uptake value of mediastinal lymph nodes on integrated FDG-PET-CT predicts pathology in patients with non–small cell lung cancer. Ann Thorac Surg. 2006;82:417–422

 Read at the Eighty-eighth Annual Meeting of The American Association for Thoracic Surgery, San Diego, California, May 10–14, 2008. Presented as part of the Point/Counterpoint Session in General Thoracic Surgery.

PII: S0022-5223(08)01473-6

doi: 10.1016/j.jtcvs.2008.08.048

The Journal of Thoracic and Cardiovascular Surgery
Volume 137, Issue 1 , Pages 20-22 , January 2009

Article Tools